The North American anticoagulants market is estimated to grow at a CAGR of 7.2% during the forecast period. An increasing approval for anticoagulants has been witnessed in the US owing to the rising incidences of heart diseases. The emerging focus on launches of generics has also been reported in the region. For instance, in June […]
